A missing protein in spinal fluid points to a new way to treat schizophrenia's cognitive symptoms
Scientists found reduced levels of a freely circulating brain protein called Cacna2d1 in the spinal fluid of schizophrenia patients. A synthetic version, SEAD1, corrected overexcited brain circuits and behavioral deficits in a mouse model with a single injection and no observable side effects.






